These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 12461788

  • 1. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H, Geng Y, Pramanik R, Choubey D.
    J Cell Biochem; 2003 Jan 01; 88(1):191-204. PubMed ID: 12461788
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M, Monjas A, Diaz-Meco MT, Serrano M, Moscat J.
    EMBO J; 1999 Nov 15; 18(22):6362-9. PubMed ID: 10562548
    [Abstract] [Full Text] [Related]

  • 4. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM, Pegg AE.
    Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A, Bruder JT, Heidaran MA, App H, Rapp UR, Aaronson SA.
    Oncogene; 1993 Sep 01; 8(9):2443-8. PubMed ID: 8361757
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathway.
    Hirota T, Irie K, Okamoto R, Ikeda W, Takai Y.
    Oncogene; 2005 Mar 24; 24(13):2229-35. PubMed ID: 15688018
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES, Conrad GW.
    Mol Vis; 2003 Jun 30; 9():277-87. PubMed ID: 12835654
    [Abstract] [Full Text] [Related]

  • 13. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L, Sánchez-Hernández I, Baquero P, Toro MJ, Chiloeches A.
    Carcinogenesis; 2009 Oct 30; 30(10):1670-7. PubMed ID: 19700418
    [Abstract] [Full Text] [Related]

  • 14. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
    Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M.
    Nature; 1991 Dec 12; 354(6353):494-6. PubMed ID: 1749429
    [Abstract] [Full Text] [Related]

  • 15. Dominant-negative Rac1 suppresses Ras-induced apoptosis possibly through activation of NFkappaB in Ha-ras oncogene-transformed NIH/3T3 cells.
    Chou CK, Liang KH, Tzeng CC, Huang GC, Chuang JI, Chang TY, Liu HS.
    Life Sci; 2006 Mar 13; 78(16):1823-9. PubMed ID: 16274703
    [Abstract] [Full Text] [Related]

  • 16. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H, Im JY, Kim J, Choi WS, Kim HS.
    Int J Mol Med; 2008 Mar 13; 21(3):325-33. PubMed ID: 18288380
    [Abstract] [Full Text] [Related]

  • 17. Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents.
    Youn CK, Kim MH, Cho HJ, Kim HB, Chang IY, Chung MH, You HJ.
    Cancer Res; 2004 Jul 15; 64(14):4849-57. PubMed ID: 15256455
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
    Zhu Y, Denhardt DT, Cao H, Sutphin PD, Koong AC, Giaccia AJ, Le QT.
    Oncogene; 2005 Sep 29; 24(43):6555-63. PubMed ID: 16007184
    [Abstract] [Full Text] [Related]

  • 19. The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domain.
    Choubey D, Gutterman JU.
    Biochem Biophys Res Commun; 1996 Apr 16; 221(2):396-401. PubMed ID: 8619867
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
    Fenton RG, Hixon JA, Wright PW, Brooks AD, Sayers TJ.
    Cancer Res; 1998 Aug 01; 58(15):3391-400. PubMed ID: 9699671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.